niflumic acid has been researched along with rofecoxib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Alpert, E; Cohen, G; Gruzman, A; Lardi-Studler, B; Reich, R; Sasson, S | 1 |
2 other study(ies) available for niflumic acid and rofecoxib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyclooxygenase-2 (PTGS2) inhibitors augment the rate of hexose transport in L6 myotubes in an insulin- and AMPKalpha-independent manner.
Topics: AMP-Activated Protein Kinases; Animals; Biological Transport; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Activation; Hexoses; Insulin; Lactones; Male; Mice; Multienzyme Complexes; Muscle Fibers, Skeletal; Muscle, Skeletal; Niflumic Acid; Protein Serine-Threonine Kinases; Rats; Sulfonamides; Sulfones | 2006 |